Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2025-05-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyMiami, FL
$153.7m
reported value
-1.0% vs Q4 2024
36positions
69.2%in top 10
4 new
2 added
1 reduced
3 sold out
vs Q4 2024
Holdings, Q1 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ALDEYRA THERAPEUTICS INC ALDX | $31.5m20.48% | Unchanged |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $20.0m12.99% | Added +70.5k |
| ENTERA BIO LTD ENTX | $10.0m6.50% | Unchanged |
| SPDR GOLD TR GLD | $9.2m6.00% | Unchanged |
| MEIRAGTX HLDGS PLC MGTX | $8.5m5.51% | Unchanged |
| AGNICO EAGLE MINES LTD AEM | $6.0m3.91% | Unchanged |
| ALTIMMUNE INC ALT | $5.6m3.65% | Unchanged |
| KINROSS GOLD CORP KGC | $5.5m3.61% | Unchanged |
| SANDSTORM GOLD LTD SSL | $5.3m3.44% | New |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $4.7m3.06% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $4.4m2.86% | Unchanged |
| FRANCO NEV CORP FNV | $3.9m2.56% | Unchanged |
| ELICIO THERAPEUTICS INC ELTX | $3.9m2.53% | New |
| APPLIED THERAPEUTICS INC APLT | $3.8m2.48% | Added +2.0m |
| EQUINOX GOLD CORP EQX | $3.8m2.47% | Unchanged |
| SEABRIDGE GOLD INC COM | $3.7m2.41% | Unchanged |
| SKEENA RES LTD NEW SKE | $3.2m2.07% | Unchanged |
| MAG SILVER CORP MAG | $2.6m1.69% | Unchanged |
| ISHARES SILVER TR SLV | $2.5m1.61% | Unchanged |
| NUVATION BIO INC NUVB | $1.8m1.17% | New |
| VISA INC V | $1.7m1.11% | Unchanged |
| PHILIP MORRIS INTL INC PM | $1.6m1.03% | Unchanged |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $1.4m0.88% | Unchanged |
| ROYAL GOLD INC RGLD | $1.2m0.80% | Unchanged |
| ISHARES TR ITA | $1.2m0.76% | Unchanged |
| NORTHROP GRUMMAN CORP NOC | $1.1m0.72% | Unchanged |
| ALAMOS GOLD INC NEW AGI | $1.1m0.71% | Unchanged |
| WHEATON PRECIOUS METALS CORP WPM | $970.4k0.63% | Unchanged |
| DIAGEO PLC DEO | $707.3k0.46% | Unchanged |
| MEREO BIOPHARMA GROUP PLC MREO | $586.1k0.38% | Unchanged |
| COEUR MNG INC CDE | $569.1k0.37% | New |
| HOOKIPA PHARMA INC COM | $538.5k0.35% | Unchanged |
| NEW PAC METALS CORP NEWP | $535.9k0.35% | Unchanged |
| VERONA PHARMA PLC VRNA | $447.5k0.29% | Reduced -193.0k |
| Orgenesis, Inc. COM | $124.0k0.08% | Unchanged |
| CARDIOL THERAPEUTICS INC CRDL | $96.9k0.06% | Unchanged |
Sold out since Q4 2024
| Security | Value then |
|---|---|
| SILVERCREST METALS INC SIL | $546.0k60.0k shares |
| GRAIL INC GRAL | $1.8k100 shares |
| OPUS GENETICS INC IRD | $5345 shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |